Company intelligence / Profile preview
BioMed Valley Discoveries
Kansas City, Missouri, United Statesbiomed-valley.com ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
BioMed Valley Discoveries is a private, clinical-stage biotechnology company focused on developing therapies for difficult-to-treat diseases—primarily oncology—by advancing early-stage assets through proof-of-concept before seeking partners for later development. Its lead asset has been ulixertinib, an ERK inhibitor targeting the MAPK pathway. The company leverages stable funding from the Stowers Institute to pursue high-risk/high-reward translational science that may be overlooked by traditional investors. As of recent data, no active interventional trials are listed publicly.
- Therapeutic areas
- OncologyRare Diseases
- Modalities
- Small molecules (notably ERK inhibitors such as ulixertinib/BVD-523)Potentially others in oncology and immuno-oncology (details limited)
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
03
Partnerships
Collaborates with academic and clinical institutions globally for early-stage development; seeks out-license partners post-proof-of-concept but no specific major pharma partnerships named publicly.
Beyond the preview
Go deeper on BioMed Valley Discoveries.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BioMed Valley Discoveries.